STOCK TITAN

Atlas Energy Stock Price, News & Analysis

CANSF OTC Link

Company Description

Willow Biosciences Inc (CANSF) was a Canadian biotechnology company that developed precision fermented ingredients for the health and wellness, food and beverage, and personal care markets. The company has since undergone a complete corporate transformation and now operates as Atlas Energy Corp., an international upstream royalty and streaming company in the oil and gas sector. Investors tracking the CANSF ticker should note that this symbol now represents Atlas Energy Corp., which trades on the TSX Venture Exchange under the symbol ATLE.

Historical Background: Willow Biosciences

Willow Biosciences was incorporated under the laws of the Province of Alberta, Canada, and was headquartered in Calgary. The company specialized in biomanufacturing processes for producing high-value ingredients across pharmaceutical, food and beverage, agriculture, and consumer markets. Willow operated two proprietary technology platforms: FutureGrown and BioOxi, which enabled large-scale fermentation production with a focus on sustainability.

The company's research and development team built expertise in developing and commercializing bio-based manufacturing processes. Willow positioned itself as a business-to-business partner, working with companies seeking sustainable alternatives to traditional ingredient sourcing. The precision fermentation approach allowed for the production of pure, consistent ingredients that could replace those derived from conventional agricultural or chemical processes.

Corporate Transformation

Willow Biosciences initiated a strategic review process to explore alternatives for maximizing shareholder value. This process culminated in the sale of its wholly-owned operating subsidiary, Epimeron USA, Inc., which housed the company's business operations, intellectual property, and research and development team. Following the disposition, Willow no longer maintained an active biotechnology business.

The company subsequently entered into a reorganization and investment agreement that resulted in a non-brokered equity private placement for gross proceeds of C$30.0 million, the appointment of a new executive team and board of directors, a share consolidation on a five-to-one basis, and a name change to Atlas Energy Corp. The common shares were delisted from the Toronto Stock Exchange and began trading on the TSX Venture Exchange.

Current Operations: Atlas Energy Corp.

Following the transformation, the company operates as Atlas Energy Corp., an international upstream royalty and streaming company. The business model focuses on the identification, acquisition, management, and monetization of a diversified portfolio of international upstream oil and gas royalty and streaming transactions. The company evaluates opportunities across global markets, with consideration for North American opportunities when available at attractive metrics.

Atlas Energy Corp. is listed on the TSXV under a Sandbox Listing designation, which indicates the company did not meet all standard listing requirements at the time of listing but has agreed to specific conditions for continued trading. The company maintains its OTC trading presence under the CANSF symbol on the OTC Pink platform, allowing United States-based investors to continue accessing the stock.

Investment Considerations

Investors researching CANSF should understand that this ticker no longer represents a biotechnology company. The fundamental business, management team, strategy, and industry focus have completely changed. The oil and gas royalty and streaming business model differs substantially from biotechnology development, involving passive income generation from mineral rights rather than active research and product development.

Royalty and streaming companies typically acquire interests in oil and gas properties in exchange for upfront payments, receiving ongoing royalty payments or product streams as the underlying resources are extracted. This model provides exposure to commodity production without the operational risks and capital requirements of direct exploration and production activities.

Stock Performance

$—
0.00%
0.00
Last updated:
-48.74 %
Performance 1 year
$73.0M

SEC Filings

No SEC filings available for Atlas Energy.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Atlas Energy (CANSF)?

The current stock price of Atlas Energy (CANSF) is $0.1313 as of January 12, 2026.

What is the market cap of Atlas Energy (CANSF)?

The market cap of Atlas Energy (CANSF) is approximately 73.0M. Learn more about what market capitalization means .

What happened to Willow Biosciences?

Willow Biosciences sold its operating subsidiary and underwent a complete corporate transformation. The company was recapitalized, renamed to Atlas Energy Corp., and pivoted from biotechnology to oil and gas royalty investments.

What is CANSF stock now?

CANSF now represents Atlas Energy Corp., an international upstream royalty and streaming company focused on oil and gas assets. The biotech business formerly operated under this ticker was sold to a third party.

Does Willow Biosciences still exist?

The Willow Biosciences brand and business operations were sold. The corporate entity was transformed into Atlas Energy Corp., which operates in an entirely different industry with new management and strategy.

Where does Atlas Energy Corp. trade?

Atlas Energy Corp. trades on the TSX Venture Exchange under the symbol ATLE. United States investors can access the stock on the OTC Pink platform under the legacy symbol CANSF.

What is an oil and gas royalty company?

A royalty and streaming company acquires interests in oil and gas properties, receiving ongoing payments as resources are extracted. This provides commodity exposure without direct operational involvement in exploration or production.

What did Willow Biosciences do before the transformation?

Willow Biosciences developed precision fermented ingredients for health and wellness, food and beverage, and personal care markets using proprietary FutureGrown and BioOxi technology platforms.

What is a TSXV Sandbox Listing?

A TSXV Sandbox Listing allows companies that do not meet all standard listing requirements to trade on the TSX Venture Exchange under specific conditions. The company must meet exit conditions to achieve full listing status.

Who acquired Willow Biosciences' biotech business?

Willow's operating subsidiary, Epimeron USA Inc., was sold to a subsidiary of Mycofeast Ltd., a privately-held entity based in the United Kingdom that continues the precision fermentation business.